Les pathologistes et le réseau d’expertise français sur les cancers ORL rares : le REFCORpath
Cécile Badoual(Inserm), B. Baujat(Sorbonne Université), Michel Wassef(Université Paris Cité), Anne–Catherine Baglin(Hôpital Lariboisière), Juliette Thariat(Centre National de la Recherche Scientifique), Émile Reyt(Centre Hospitalier Universitaire de Nantes), François Janot(Centre Hospitalier Universitaire de Nantes)
Cited by 19
Related Papers
Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies
|PEDIATRICS|2015|1.4k
Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas
|The Journal of Pediatrics|1997|499
The immune paradox of sarcoidosis and regulatory T cells
|The Journal of Experimental Medicine|2006|444
Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study
|Journal of Clinical Oncology|2013|418
Rapidly Involuting Congenital Hemangioma: Clinical and Histopathologic Features
|Pediatric and Developmental Pathology|2003|360